Haas GP - Search Results

1

Immunotherapy with interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer with in situ primary cancers: a pilot study.

Spencer WF, Linehan WM, Walther MM, Haas GP, Lotze MT, Topalian SL, Yang JC, Merino MJ, Lange JR, Pockaj BA, et al. Spencer WF, et al. Among authors: haas gp. J Urol. 1992 Jan;147(1):24-30. doi: 10.1016/s0022-5347(17)37124-0. J Urol. 1992. PMID: 1729540

2

Renal cell carcinoma: resection of solitary and multiple metastases.

Pogrebniak HW, Haas G, Linehan WM, Rosenberg SA, Pass HI. Pogrebniak HW, et al. Ann Thorac Surg. 1992 Jul;54(1):33-8. doi: 10.1016/0003-4975(92)91136-w. Ann Thorac Surg. 1992. PMID: 1610251 Review.

3

Preparative cytoreductive surgery in patients with metastatic renal cell carcinoma treated with adoptive immunotherapy with interleukin-2 or interleukin-2 plus lymphokine activated killer cells.

Robertson CN, Linehan WM, Pass HI, Gomella LG, Haas GP, Berman A, Merino M, Rosenberg SA. Robertson CN, et al. Among authors: haas gp. J Urol. 1990 Sep;144(3):614-7; discussion 617-8. doi: 10.1016/s0022-5347(17)39537-x. J Urol. 1990. PMID: 2201792 Clinical Trial.

4

Clinically occult Leydig cell tumor presenting with gynecomastia.

Haas GP, Pittaluga S, Gomella L, Travis WD, Sherins RJ, Doppman JL, Linehan WM, Robertson C. Haas GP, et al. J Urol. 1989 Nov;142(5):1325-7. doi: 10.1016/s0022-5347(17)39077-8. J Urol. 1989. PMID: 2810523

5

Expansion of tumor-infiltrating lymphocytes from human tumors using the T-cell growth factors interleukin-2 and interleukin-4.

Kawakami Y, Haas GP, Lotze MT. Kawakami Y, et al. Among authors: haas gp. J Immunother Emphasis Tumor Immunol. 1993 Nov;14(4):336-47. doi: 10.1097/00002371-199311000-00014. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8280717

6

Synergy of radiation therapy and immunotherapy in murine renal cell carcinoma.

Dybal EJ, Haas GP, Maughan RL, Sud S, Pontes JE, Hillman GG. Dybal EJ, et al. Among authors: haas gp. J Urol. 1992 Oct;148(4):1331-7. doi: 10.1016/s0022-5347(17)36903-3. J Urol. 1992. PMID: 1404669

7

Intralesional treatment of established murine primary renal tumor with interleukin-4: localized effect on primary tumor with no impact on metastases.

Younes E, Haas GP, Visscher D, Pontes JE, Puri RK, Hillman GG. Younes E, et al. Among authors: haas gp. J Urol. 1995 Feb;153(2):490-3. doi: 10.1097/00005392-199502000-00068. J Urol. 1995. PMID: 7815631

8

Radiation-induced effects on murine kidney tumor cells: role in the interaction of local irradiation and immunotherapy.

Younes E, Haas GP, Dezso B, Ali E, Maughan RL, Montecillo E, Pontes JE, Hillman GG. Younes E, et al. Among authors: haas gp. J Urol. 1995 Jun;153(6):2029-33. doi: 10.1016/s0022-5347(01)67396-8. J Urol. 1995. PMID: 7752388

9

Phase II trial of sequential radiation and interleukin 2 in the treatment of patients with metastatic renal cell carcinoma.

Redman BG, Hillman GG, Flaherty L, Forman J, Dezso B, Haas GP. Redman BG, et al. Among authors: haas gp. Clin Cancer Res. 1998 Feb;4(2):283-6. Clin Cancer Res. 1998. PMID: 9516912 Clinical Trial.

10

Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer by Pattern of Metastatic Spread: ARCHES Post Hoc Analyses.

Armstrong AJ, Shore ND, Szmulewitz RZ, Petrylak DP, Holzbeierlein J, Villers A, Azad A, Alcaraz A, Alekseev B, Iguchi T, Gomez-Veiga F, Rosbrook B, Lee HJ, Haas GP, Stenzl A. Armstrong AJ, et al. Among authors: haas gp. J Urol. 2021 May;205(5):1361-1371. doi: 10.1097/JU.0000000000001568. Epub 2020 Dec 28. J Urol. 2021. PMID: 33356529 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters